Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 15, 2014 - Issue 11
Submit an article Journal homepage
480
Views
19
CrossRef citations to date
0
Altmetric
Drug Evaluations

Oral vinorelbine in the treatment of non-small-cell lung cancer

Giulia BarlettaUOS Tumori Polmonari, IRCCS AOU San Martino – IST Istituto Nazionale per la Ricerca sul Cancro, Genova, [email protected]
,
Carlo GenovaUOS Tumori Polmonari, IRCCS AOU San Martino – IST Istituto Nazionale per la Ricerca sul Cancro, Genova, [email protected]
,
Erika RijavecUOS Tumori Polmonari, IRCCS AOU San Martino – IST Istituto Nazionale per la Ricerca sul Cancro, Genova, [email protected]
,
Giovanni BurrafatoUOS Tumori Polmonari, IRCCS AOU San Martino – IST Istituto Nazionale per la Ricerca sul Cancro, Genova, [email protected]
,
Federica BielloUOS Tumori Polmonari, IRCCS AOU San Martino – IST Istituto Nazionale per la Ricerca sul Cancro, Genova, [email protected]
,
Claudio SiniUOS Tumori Polmonari, IRCCS AOU San Martino – IST Istituto Nazionale per la Ricerca sul Cancro, Genova, [email protected]
,
Maria Giovanna Dal BelloUOS Tumori Polmonari, IRCCS AOU San Martino – IST Istituto Nazionale per la Ricerca sul Cancro, Genova, [email protected]
,
Simona CocoUOS Tumori Polmonari, IRCCS AOU San Martino – IST Istituto Nazionale per la Ricerca sul Cancro, Genova, [email protected]
,
Anna TruiniUOS Tumori Polmonari, IRCCS AOU San Martino – IST Istituto Nazionale per la Ricerca sul Cancro, Genova, [email protected];Università di Genova, Dipartimento di Medicina Interna e Specialità Mediche (DIMI), Genova, Italy
,
Irene VanniUOS Tumori Polmonari, IRCCS AOU San Martino – IST Istituto Nazionale per la Ricerca sul Cancro, Genova, [email protected]
,
Angela AlamaUOS Tumori Polmonari, IRCCS AOU San Martino – IST Istituto Nazionale per la Ricerca sul Cancro, Genova, [email protected]
,
Sabrina BeltraminiUO Farmacia, IRCCS AOU San Martino – IST Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy
,
Maria Attilia GrassiUO Farmacia, IRCCS AOU San Martino – IST Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy
,
Francesco BoccardoUO Clinica di Oncologia Medica, IRCCS AOU San Martino IST – Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy;Università di Genova, Dipartimento di Medicina Interna e Specialità Mediche (DIMI), Genova, Italy
&
Francesco GrossiUOS Tumori Polmonari, IRCCS AOU San Martino – IST Istituto Nazionale per la Ricerca sul Cancro, Genova, [email protected]
 show all
Pages 1585-1599 | Published online: 27 Jun 2014

Citations (19)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Paul Lesueur, Isabelle Martel-Laffay, Alexandre Escande, Manon Kissel, Chrystel Locher, Radj Gervais, Roland Schott, Alain Vergnenegre & Christos Chouaid. (2018) Oral vinorelbine-based concomitant chemoradiotherapy in unresectable stage III non-small cell lung cancer: a systematic review. Expert Review of Anticancer Therapy 18:11, pages 1159-1165.
Read now
Ciro Battiloro, Luigi Della Gravara, Danilo Rocco & Cesare Gridelli. (2018) What pharmacotherapeutics should one use for early stage non-small cell lung cancer?. Expert Opinion on Pharmacotherapy 19:13, pages 1403-1406.
Read now
C. Genova, A. Alama, S. Coco, E. Rijavec, MG. Dal Bello, I. Vanni, F. Biello, G. Barletta, G. Rossi & F. Grossi. (2016) Vinflunine for the treatment of non-small cell lung cancer. Expert Opinion on Investigational Drugs 25:12, pages 1447-1455.
Read now
Francesco Grossi, Jaafar Bennouna, Libor Havel, Maximillian Hochmair & Teresa Almodovar. (2016) Oral vinorelbine plus cisplatin versus pemetrexed plus cisplatin as first-line treatment of advanced non-squamous non-small-cell lung cancer: cost minimization analysis in 12 European countries. Current Medical Research and Opinion 32:9, pages 1577-1584.
Read now
Xuan He, Ji Wang & Yuanmin Li. (2015) Efficacy and safety of docetaxel for advanced non-small-cell lung cancer: a meta-analysis of Phase III randomized controlled trials. OncoTargets and Therapy 8, pages 2023-2031.
Read now

Articles from other publishers (14)

Fernanda Estevinho, Rita Gomes, Direndra Hasmucrai & Fernando Barata. (2022) Metronomic oral vinorelbine in a real-world population of advanced non-small cell lung cancer patients. Pulmonology 28:5, pages 368-375.
Crossref
C. R. Arnold, A. K. Lindner, G. Schachtner, G. Tulchiner, N. Tulchiner, J. Mangesius, M. Maffei, W. Horninger, O. Kouvaiou, P. Lukas, U. Ganswindt, R. Pichler & S. Skvortsov. (2021) Vinorelbine in bladder-preserving multimodality treatment for muscle-invasive bladder cancer—a valid option for cisplatin-unfit patients?. Strahlentherapie und Onkologie 198:1, pages 25-32.
Crossref
Maria Kandi, Peter Meldgaard & Marianne Marquard Knap. (2021) Metronomic oral vinorelbine doublet chemotherapy with carboplatin in treatment of advanced lung cancer: a feasibility and safety study. F1000Research 10, pages 673.
Crossref
Francesco Grossi, Piotr Jaśkiewicz, Marion Ferreira, Grzegorz Czyżewicz, Dariusz Kowalski, Libero Ciuffreda, Ramon Garcia-Gomez, Salvatore Caruso, Joaquim Bosch-Barrera, Stéphanie Gautier, Christine Ta Thanh Minh, Sébastien Henriet & Gilberto de CastroJr.Jr.. (2021) Oral vinorelbine and cisplatin as first-line therapy for advanced squamous NSCLC patients: a prospective randomized international phase II study (NAVoTrial 03). Therapeutic Advances in Medical Oncology 13, pages 175883592110229.
Crossref
Lokman KORAL. (2020) METASTATİK KÜÇÜK HÜCRE DIŞI AKCİĞER KANSERİNDE ORAL VİNORELBİNİN ÜÇÜNCÜ SERİ TEDAVİDE ETKİNLİK VE TOKSİSİTE DEĞERLENDİRMESİ: TEK MERKEZ DENEYİMİ. Namık Kemal Tıp Dergisi.
Crossref
Sushma Jonna, Joshua E. Reuss, Chul Kim & Stephen V. Liu. (2020) Oral Chemotherapy for Treatment of Lung Cancer. Frontiers in Oncology 10.
Crossref
Clarissa A. Whitehead, Hong P.T. Nguyen, Andrew P. Morokoff, Rodney B. Luwor, Lucia Paradiso, Andrew H. Kaye, Theo Mantamadiotis & Stanley S. Stylli. (2018) Inhibition of Radiation and Temozolomide-Induced Invadopodia Activity in Glioma Cells Using FDA-Approved Drugs. Translational Oncology 11:6, pages 1406-1418.
Crossref
Paola Orlandi, Teresa Di Desidero, Giada Salvia, Beatrice Muscatello, Giulio Francia & Guido Bocci. (2018) Metronomic vinorelbine is directly active on Non Small Cell Lung Cancer cells and sensitizes the EGFRL858R/T790M cells to reversible EGFR tyrosine kinase inhibitors. Biochemical Pharmacology 152, pages 327-337.
Crossref
Carole Farrell, Victoria Harmer, Mark Foulkes & Tom Allum. (2018) Oral vinorelbine: a narrative review. Cancer Nursing Practice 17:2, pages 25-33.
Crossref
Joseph Ciccolini, Dominique Barbolosi, Christophe Meille, Aurélie Lombard, Cindy Serdjebi, Sarah Giacometti, Laetitia Padovani, Eddy Pasquier & Nicolas André. (2017) Pharmacokinetics and Pharmacodynamics-Based Mathematical Modeling Identifies an Optimal Protocol for Metronomic Chemotherapy. Cancer Research 77:17, pages 4723-4733.
Crossref
Karla A. Ruiz-Ceja & Yolanda I. Chirino. (2017) Current FDA-approved treatments for non-small cell lung cancer and potential biomarkers for its detection. Biomedicine & Pharmacotherapy 90, pages 24-37.
Crossref
Øystein Fløtten, Bjørn Henning Grønberg, Stein Sundstrøm, Nina Helbekkmo, Roy Bremnes & Christian von Plessen. (2016) Oral versus intravenous vinorelbine in advanced NSCLC—a retrospective comparison. Cancer Treatment and Research Communications 9, pages 15-20.
Crossref
M.G. Dal Bello, A. Alama, G. Barletta, S. Coco, A. Truini, I. Vanni, S. Boccardo, C. Genova, E. Rijavec, F. Biello, G. Bottoni, G. Sambuceti & F. Grossi. (2015) Sequential use of vinorelbine followed by gefitinib enhances the antitumor effect in NSCLC cell lines poorly responsive to reversible EGFR tyrosine kinase inhibitors . International Journal of Cancer 137:12, pages 2947-2958.
Crossref
P. Katsaounis, A. Kotsakis, S. Agelaki, E. Kontopodis, A. Agelidou, N. Kentepozidis, L. Vamvakas, A. Christopoulou, N. Karachaliou, D. Hatzidaki & V. Georgoulias. (2015) Cisplatin in combination with metronomic vinorelbine as front-line treatment in advanced non-small cell lung cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG). Cancer Chemotherapy and Pharmacology 75:4, pages 821-827.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.